On May 8, 2023 Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, reported that its President and CEO, Robert E. Hoffman, will present a corporate overview at the Sidoti Micro-Cap Virtual Conference being held on May 10 – 11, 2023 (Press release, Kintara Therapeutics, MAY 8, 2023, View Source [SID1234631169]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Presentation Date:

Wednesday, May 10, 2023

Time:

4:00 pm ET

Webcast Link:

Kintara Presentation Registration